Sunobinop (developmental code names V117957; IMB-115) is a high affinity small molecule nociceptin receptor partial agonist. As of Feb 2024, it is under...
5 KB (341 words) - 05:42, 13 May 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
118 KB (11,362 words) - 03:35, 26 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
173 KB (15,979 words) - 10:21, 26 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
34 KB (3,196 words) - 06:07, 15 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
140 KB (13,709 words) - 18:15, 16 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
130 KB (11,783 words) - 08:48, 16 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
47 KB (4,108 words) - 05:59, 15 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
222 KB (19,669 words) - 18:52, 20 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
117 KB (11,946 words) - 04:04, 13 August 2024
Racemorphan Ro64-6198 Ro65-6570 SCH-221510 SCH-486757 SR-8993 SR-16435 Sunobinop (S-117957) TH-030418 Antagonists (Nphe1)Nociceptin(1-13)NH2 AT-076 BAN-ORL-24...
124 KB (11,463 words) - 17:07, 23 August 2024